Plants. • THB 99.68 million of loss from impairment of investment in Power Plants • THB 69.87 million of loss from impairment of investment in associates • THB 64.69 million of provision on project under

, 2020 Subject Management’ Discussion and Analysis for the 1st Quarter in 2020 To Directors & Managers The Stock Exchange of Thailand Inter Pharma Public Company Limited (“the Company”) hereby submitting

1 IDH-AC-000-อส6211/08.00 8 November 2019 Re: Management Discussion and Analysis Operating results for the three-month and nine-month period ended 30 September 2019 To: President The Stock Exchange

lending agreement for a short selling through a margin account shall comply with the requirements stipulated by the Stock Exchange of Thailand and approved by the SEC Office. Chapter 4 Provision on

selling through a margin account shall comply with the requirements stipulated by the Stock Exchange of Thailand and approved by the SEC Office. Chapter 4 Provision on Investment Analysis and Consultation

) - Translation - Ref. WINNER 0009/2018 February 28, 2018 Re Information Memorandum on Acquiring of Ordinary Shares in Aesthetic Zecret (At-Ze) Co., Ltd. (Additional info.2) To The President The Stock Exchange of

credit foncier company under the Financial Institutions Businesses Act, B.E. 2551. “Stock Exchange” means the Stock Exchange of Thailand. “subordinated bond” means an unsecured bond where the rights of the

for the year ended December 31, 2019 To Director and Manager of the Stock Exchange of Thailand Referring to the submission of the audited financial statements of WIIK Public Company Limited “the Company

แบบแสดงรายการข้อมูลสำหรับการเสนอขายหลักทรัพย์ (แบบ 69-1) 1 No. WHAUP-CS009/2562 May 09, 2019 Attention: Managing Director – Stock Exchange of Thailand Subject: Report of Financial Results for the

prices and the Company suffered devaluation loss on Finished Goods stock, Raw Material in stock and in transit as explained above. Though the prices have continued to weaken month on month, we are now